TegoScience Inc Cash Flow-to-Debt Ratio
TegoScience Inc cash flow-to-debt ratio. TegoScience Inc (191420) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of ₩-700.37 Million could theoretically repay 0% of its total liabilities (₩32.78 Billion) in one year. Check TegoScience Inc (191420) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of TegoScience Inc (2015–2025)
Cash flow-to-debt ratio of TegoScience Inc from 2015 to 2025. Historical debt coverage capacity for TegoScience Inc across 11 annual periods. Check cash flow reinvestment rate of TegoScience Inc to assess the company's total reinvestment commitment from operating cash flow.
TegoScience Inc Cash Flow-to-Debt Ratio by Year (2015–2025)
TegoScience Inc cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for TegoScience Inc. For the full cash flow conversion analysis, see TegoScience Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | ₩-3.07 Billion | ₩27.83 Billion | ▲ +74.8% |
| 2024 | -0.44x | ₩-1.16 Billion | ₩2.66 Billion | ▼ -42.0% |
| 2023 | -0.31x | ₩-794.61 Million | ₩2.58 Billion | ▼ -181.8% |
| 2022 | 0.38x | ₩1.04 Billion | ₩2.77 Billion | ▲ +108.0% |
| 2021 | 0.18x | ₩457.25 Million | ₩2.53 Billion | ▼ -80.0% |
| 2020 | 0.91x | ₩1.28 Billion | ₩1.41 Billion | ▲ +1541.7% |
| 2019 | 0.06x | ₩41.40 Million | ₩750.71 Million | ▼ -94.2% |
| 2018 | 0.95x | ₩833.88 Million | ₩882.02 Million | ▲ +291.7% |
| 2017 | 0.24x | ₩2.87 Billion | ₩11.87 Billion | ▲ +91.1% |
| 2016 | 0.13x | ₩2.36 Billion | ₩18.66 Billion | ▼ -97.4% |
| 2015 | 4.77x | ₩2.63 Billion | ₩551.82 Million | — |